SCHEMBL7894271

SCHEMBL7894271

CC(C)[Si]1(C(C)C)OC[C@H]2O[C@@H](n3cnc4c(N)nc(F)nc43)C[C@@H]2O[Si](C(C)C)(C(C)C)O1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHCY P23526 4/20 0.46
▸ STING1 Q86WV6 5/20 0.41
▸ LMNA P02545 2/20 0.40
▸ NT5E P21589 2/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ CA5A P35218 1/20 0.37
▸ ADORA3 P0DMS8 1/20 0.37
▸ ADORA2A P29274 1/20 0.37
▸ ADORA2B P29275 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ PNP P00491 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ PDE4D Q08499 1/20 0.37
▸ PDE3A Q14432 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ CHKA P35790 1/20 0.35
▸ DNMT1 P26358 1/20 0.35
▸ DNMT3B Q9UBC3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6899409 0.89 PDE4D (0.49) STING1LMNANT5EADORA3ADORA2A
SCHEMBL12352439 0.85 STING1 (0.52) AHCYSTING1ADORA3ADORA2AADORA2B
SCHEMBL12595500 0.85 STING1 (0.52) AHCYSTING1ADORA3ADORA2AADORA2B
SCHEMBL8624094 0.85 STING1 (0.52) AHCYSTING1ADORA3ADORA2AADORA2B
SCHEMBL17772331 0.85 STING1 (0.52) AHCYSTING1ADORA3ADORA2AADORA2B
SCHEMBL12729578 0.85 STING1 (0.52) AHCYSTING1ADORA3ADORA2AADORA2B
SCHEMBL12222444 0.85 STING1 (0.52) AHCYSTING1ADORA3ADORA2AADORA2B
SCHEMBL10719650 0.85 ADORA3 (0.37) STING1LMNANT5EADORA3PNP
SCHEMBL8668421 0.83 NT5E (0.36) STING1LMNANT5EPNPTP53
SCHEMBL8594450 0.82 AHCY (0.50) AHCYSTING1LMNANT5EHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6175004-B1 REACTING AN OLIGONUCLEOTIDE COMPRISING A HALOGENATED PURINE NUCLEOSIDE WITH AMINE; FOR STRONGER HYBRIDIZATION; DIAGNOSIS; GENETIC ENGINEERING; ANTISENSE AGENTS ISIS PHARMACEUTICALS, INC. 2001-01-16 — — US disclosed
Send feedback